Table 3.
Timeliness of vaccination by 24 months among American Indian/Alaska Native and non-Hispanic White Montana children born 2015–2017, by race/ethnicity (n = 21,652).
American Indian/Alaska Native n = 3,630 |
Non-Hispanic White n = 18,022 |
||||||
---|---|---|---|---|---|---|---|
Vaccine series |
All doses, all on time n (column %) |
All doses, but not all on time n (column %) |
Missing some or all doses n (column %) |
All doses, all on time n (column %) |
All doses, but not all on time n (column %) |
Missing some or all doses n (column %) |
Chi-squarep-value |
Combined 7-vaccine series | 839 (23.1) | 1214 (33.4) | 1577 (43.4) | 7284 (40.4) | 4308 (23.9) | 6430 (35.7) | < 0.001 |
Vaccines in combined 7-vaccine series: | |||||||
Hepatitis B, 3 doses | 2881 (79.4) | 449 (12.4) | 300 (8.3) | 15,436 (85.7) | 910 (5.1) | 1676 (9.3) | < 0.001 |
Diphtheria-tetanus-acellular pertussis, 4 doses | 1077 (29.7) | 1322 (36.4) | 1231 (33.9) | 10,052 (55.8) | 4050 (22.5) | 3920 (21.8) | < 0.001 |
Haemophilus influenzae type b, 3 or 4 dosesa | 1536 (42.3) | 1255 (34.6) | 839 (23.1) | 11,243 (62.4) | 2770 (15.4) | 4009 (22.3) | < 0.001 |
Pneumococcal conjugate, 4 doses | 1252 (34.5) | 1217 (33.5) | 1161 (32.0) | 11,045 (61.3) | 3288 (18.2) | 3689 (20.5) | < 0.001 |
Poliovirus, 3 doses | 1898 (52.3) | 1296 (35.7) | 436 (12.0) | 13,849 (76.8) | 2502 (13.9) | 1671 (9.3) | < 0.001 |
Measles-mumps-rubella, 1 dose | 2521 (69.5) | 742 (20.4) | 367 (10.1) | 14,252 (79.1) | 2270 (12.6) | 1500 (8.3) | < 0.001 |
Varicella, 1 dose | 2473 (68.1) | 742 (20.4) | 415 (11.4) | 13,772 (76.4) | 2392 (13.3) | 1858 (10.3) | < 0.001 |
a Depending on brand.